February 27, 2025 - 00:57

Cambridge Innovation Capital has unveiled a new scaleup fund aimed at addressing the significant finance gap faced by early-stage companies in the U.K. This initiative is designed to provide crucial support to businesses that are ready to expand but struggle to secure the necessary funding. Partner Andrew Williamon highlighted the challenges that many promising startups encounter as they transition from early-stage funding to the scaleup phase, where traditional financing options often fall short.
The fund seeks to fill this void by offering tailored financial solutions that align with the unique needs of scaleups. Williamon emphasized the importance of fostering innovation and growth within the U.K. economy, particularly in the technology and life sciences sectors, which are critical to the nation's competitive edge. By facilitating access to capital, this new fund aims to empower entrepreneurs to accelerate their growth trajectories and contribute to job creation and economic development across the region.
September 28, 2026 - 02:08
Finance Expert Explains How Kylian Mbappe Can Reach LeBron James Status in the USSoccer finance expert Professor Rob Wilson has shared his perspective on how Kylian Mbappe can build a commercial presence in the United States that rivals stars like LeBron James and Travis Kelce....
September 27, 2026 - 02:05
3 Stocks Tied To Foreign Buying In US Markets Investors May Be MissingForeign buyers have quietly become major forces in US equities. Roughly 942 billion dollars flowed into American shares and funds in the 12 months ending in July, and the second quarter of 2026...
September 26, 2026 - 02:31
MVB Bank Announces Strategic Partnership With DingoBlu FinancialFAIRMONT, W.Va., September 25, 2026 -- DingoBlu Financial, Inc., a financial technology company developing a mobile-first platform for personal financial products, today announced a strategic...
September 25, 2026 - 00:58
NANOBIOTIX Provides First Half 2026 Operational and Financial UpdateNanobiotix has released its operational and financial update for the first half of 2026, highlighting progress across its clinical programs and a significantly improved financial standing. The...